Difference between revisions of "Levofloxacin (Levaquin)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | ||
| + | |||
| + | ==References== | ||
| + | # Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005 Sep 8;353(10):977-87. [http://www.nejm.org/doi/full/10.1056/NEJMoa044097 link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/16148283 PubMed] | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
Revision as of 22:29, 30 January 2018
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties.
References
- Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005 Sep 8;353(10):977-87. link to original article PubMed